ERAS
Price
$16.23
Change
-$0.03 (-0.18%)
Updated
Sep 4, 11:08 AM (EDT)
Capitalization
5.69B
68 days until earnings call
Intraday BUY SELL Signals
RZLT
Price
$4.59
Change
+$0.05 (+1.10%)
Updated
Sep 4, 12:05 PM (EDT)
Capitalization
436.2M
6 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ERAS vs RZLT

ERAS vs RZLT Comparison Chart in %
View a ticker or compare two or three
VS
ERAS vs. RZLT commentary
Sep 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ERAS is a StrongBuy and RZLT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2026
Stock price -- (ERAS: $16.26 vs. RZLT: $4.54)
Brand notoriety: ERAS and RZLT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ERAS: 97% vs. RZLT: 47%
Market capitalization -- ERAS: $5.69B vs. RZLT: $436.2M
ERAS [@Biotechnology] is valued at $5.69B. RZLT’s [@Biotechnology] market capitalization is $436.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $141.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ERAS’s FA Score shows that 0 FA rating(s) are green whileRZLT’s FA Score has 1 green FA rating(s).

  • ERAS’s FA Score: 0 green, 5 red.
  • RZLT’s FA Score: 1 green, 4 red.
According to our system of comparison, both ERAS and RZLT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ERAS’s TA Score shows that 2 TA indicator(s) are bullish while RZLT’s TA Score has 2 bullish TA indicator(s).

  • ERAS’s TA Score: 2 bullish, 7 bearish.
  • RZLT’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, RZLT is a better buy in the short-term than ERAS.

Price Growth

ERAS (@Biotechnology) experienced а -16.57% price change this week, while RZLT (@Biotechnology) price change was -8.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.51%. For the same industry, the average monthly price growth was +6.00%, and the average quarterly price growth was +2377.30%.

Reported Earning Dates

ERAS is expected to report earnings on Nov 11, 2026.

RZLT is expected to report earnings on Sep 10, 2026.

Industries' Descriptions

@Biotechnology (+0.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ERAS($5.69B) has a higher market cap than RZLT($436M). ERAS YTD gains are higher at: 337.097 vs. RZLT (92.373). RZLT has higher annual earnings (EBITDA): -87.22M vs. ERAS (-130.68M). ERAS has more cash in the bank: 244M vs. RZLT (120M). RZLT has less debt than ERAS: RZLT (1.11M) vs ERAS (46M). ERAS (0) and RZLT (0) have equivalent revenues.
ERASRZLTERAS / RZLT
Capitalization5.69B436M1,304%
EBITDA-130.68M-87.22M150%
Gain YTD337.09792.373365%
P/E RatioN/AN/A-
Revenue00-
Total Cash244M120M203%
Total Debt46M1.11M4,140%
FUNDAMENTALS RATINGS
RZLT: Fundamental Ratings
RZLT
OUTLOOK RATING
1..100
90
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ERASRZLT
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ERAS
Daily Signal:
Gain/Loss:
RZLT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BCHP38.580.42
+1.10%
Principal Focused Blue Chip ETF
CLSE34.010.14
+0.41%
Convergence Long/Short Equity ETF
IUSB45.230.05
+0.11%
iShares Core Universal USD Bond ETF
CPII19.06N/A
N/A
American Beacon Ionic Inflation Prot ETF
TSLS54.57-3.09
-5.36%
Direxion Daily TSLA Bear 1X Shares